New MD for MEC Resources as it seeks to expand energy portfolio

|

Published 08-OCT-2018 11:32 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

The Board of MEC Resources Ltd (ASX:MMR) today announced that it has appointed Ms Deborah Ambrosini as the Managing Director of the company effective immediately.

Ambrosini has extensive experience with MEC Resources, having been with the company for over 10 years as the CFO, Company Secretary and Executive Director and will continue in her role as CFO and Company Secretary.

Ambrosini is a fellow of the Chartered Accountants Australia and New Zealand with over 20 years’ experience in management, accounting and business development.

Her experience spans the resources, IT communications, biotechnology and financial services sectors. She has extensive experience both nationally and internationally in financial and business planning, compliance and taxation.

Ambrosini was a former state finalist in the Telstra Business Woman Awards and a recipient of the highly regarded ’40 under 40’ award held by the WA Business News.

The terms of Ambrosini’s contract remain unchanged, as previously reported in the 2018 Annual Accounts.

Today’s announcement comes a week after we reported that since July MMR has restructured its Board and announced several major changes to its main investee, the unlisted oil and gas exploration company Advent Energy Ltd. It has also flagged a new direction for the company, hinting strongly at the potential for expanding its investment portfolio beyond oil and gas, and into renewable energy.

The company’s annual report, which was released on September 28, outlined its new direction and noted its ‘significant unrealised potential, especially considering its status as an ASX listed Pooled Development Fund’.

Overall this is an early stage play and as such any investment decision should be made with caution and professional financial advice should be sought.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X